These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 478645)

  • 1. Immunization of mice against coccidioidomycosis with a subcellular vaccine.
    Pappagianis D; Hector R; Levine HB; Collins MS
    Infect Immun; 1979 Jul; 25(1):440-5. PubMed ID: 478645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.
    Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D
    Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.
    Lecara G; Cox RA; Simpson RB
    Infect Immun; 1983 Jan; 39(1):473-5. PubMed ID: 6822433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the protective subcellular coccidioidal T27K vaccine.
    Johnson SM; Kerekes KM; Lunetta JM; Pappagianis D
    Ann N Y Acad Sci; 2007 Sep; 1111():275-89. PubMed ID: 17363436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
    Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
    Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
    Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
    Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
    Jiang C; Magee DM; Quitugua TN; Cox RA
    Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
    Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
    Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of vaccines for coccidioidomycosis.
    Levine HB; Pappagianis D; Cobb JM
    Mycopathol Mycol Appl; 1970; 41(1):177-85. PubMed ID: 4999877
    [No Abstract]   [Full Text] [Related]  

  • 11. Coccidioidomycosis: host response and vaccine development.
    Cox RA; Magee DM
    Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
    Pappagianis D
    Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
    Jiang C; Magee DM; Ivey FD; Cox RA
    Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
    Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
    Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An immunologic evaluation of several Coccidioides immitis antigens].
    Semakova NG
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Aug; 47(8):56-9. PubMed ID: 5503343
    [No Abstract]   [Full Text] [Related]  

  • 16. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
    Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
    Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
    Herr RA; Hung CY; Cole GT
    Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and morphology of an immunoreactive outer wall fraction produced by spherules of Coccidioides immitis.
    Cole GT; Seshan KR; Franco M; Bukownik E; Sun SH; Hearn VM
    Infect Immun; 1988 Oct; 56(10):2686-94. PubMed ID: 3138180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
    Xue J; Hung CY; Yu JJ; Cole GT
    Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression by cell wall antigens of Coccidioides immitis.
    Cox RA
    Rev Infect Dis; 1988; 10 Suppl 2():S415-8. PubMed ID: 3263691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.